Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 167

1.

Focal thyroid incidentalomas identified with whole-body FDG-PET warrant further investigation.

Prichard RS, Cotter M, Evoy D, Gibbons D, Collins C, McDermott E, Skehan S.

Ir Med J. 2011 Jun;104(6):177-9.

PMID:
22111394
2.

Thyroid incidentalomas discovered on positron emission tomography CT scanning - Malignancy rate and significance of standardised uptake values.

Brindle R, Mullan D, Yap BK, Gandhi A.

Eur J Surg Oncol. 2014 Nov;40(11):1528-32. doi: 10.1016/j.ejso.2014.05.005. Epub 2014 May 24.

PMID:
24915858
3.

Incidental thyroid "PETomas": clinical significance and novel description of the self-resolving variant of focal FDG-PET thyroid uptake.

Nishimori H, Tabah R, Hickeson M, How J.

Can J Surg. 2011 Apr;54(2):83-8. doi: 10.1503/cjs.023209.

4.

Thyroid incidentalomas in FDG-PET/CT: prevalence and clinical impact.

Bonabi S, Schmidt F, Broglie MA, Haile SR, Stoeckli SJ.

Eur Arch Otorhinolaryngol. 2012 Dec;269(12):2555-60.

PMID:
22298251
5.

Effect of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography-guided management of suspected recurrent papillary thyroid carcinoma: long-term follow-up with tumour marker responses.

Dennis K, Hay JH, Wilson DC.

Clin Oncol (R Coll Radiol). 2012 Dec;24(10):e168-72. doi: 10.1016/j.clon.2012.08.002. Epub 2012 Sep 1.

PMID:
22944464
6.

Thyroid incidentalomas on fluorine-18-fluorodeoxyglucose positron emission tomography-computed tomography: incidence, malignancy risk, and comparison of standardized uptake values.

Kao YH, Lim SS, Ong SC, Padhy AK.

Can Assoc Radiol J. 2012 Nov;63(4):289-93. doi: 10.1016/j.carj.2011.04.003. Epub 2011 Dec 3.

7.
9.

Incidental ¹⁸F-FDG uptake in the thyroid in patients diagnosed with PET/CT for other malignancies.

Czepczyński R, Stangierski A, Oleksa R, Janicka-Jedyńska M, Czarnywojtek A, Ruchała M, Sowiński J.

Nucl Med Rev Cent East Eur. 2011;14(2):68-72.

10.

[Interpretation of thyroid incidentalomas in (18)F-FDG PET/CT studies].

Achury C, Estorch M, Domènech A, Camacho V, Flotats A, Jaller R, Geraldo L, Deportós J, Montes A, Carrió I.

Rev Esp Med Nucl Imagen Mol. 2014 Jul-Aug;33(4):205-9. doi: 10.1016/j.remn.2013.12.006. Epub 2014 Feb 21. Spanish.

11.

Thyroid incidentalomas on 18FDG-PET/CT: a metabolico-pathological correlation.

Hagenimana N, Dallaire J, Vallée É, Belzile M.

J Otolaryngol Head Neck Surg. 2017 Mar 21;46(1):22. doi: 10.1186/s40463-017-0200-8.

12.

The role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography whole body imaging in the evaluation of focal thyroid incidentaloma.

Zhai G, Zhang M, Xu H, Zhu C, Li B.

J Endocrinol Invest. 2010 Mar;33(3):151-5. doi: 10.3275/6499. Epub 2009 Sep 11.

PMID:
19783895
13.

Utility of fluorine-18-fluorodeoxyglucose positron emission tomography in differentiated thyroid carcinoma with negative radioiodine scans and elevated serum thyroglobulin levels.

Muros MA, Llamas-Elvira JM, Ramírez-Navarro A, Gómez MJ, Rodríguez-Fernández A, Muros T, López de la Torre M, Becerra A, Carreras JL.

Am J Surg. 2000 Jun;179(6):457-61.

PMID:
11004330
14.

Clinical significance of focal and diffuse thyroid diseases identified by (18)F-fluorodeoxyglucose positron emission tomography.

Salvatori M, Melis L, Castaldi P, Maussier ML, Rufini V, Perotti G, Rubello D.

Biomed Pharmacother. 2007 Sep;61(8):488-93. Epub 2007 Jun 13.

PMID:
17604940
15.

Focal uptake of (18)F-fluorodeoxyglucose by thyroid in patients with nonthyroidal head and neck cancers.

Nam SY, Roh JL, Kim JS, Lee JH, Choi SH, Kim SY.

Clin Endocrinol (Oxf). 2007 Jul;67(1):135-9. Epub 2007 Apr 27.

PMID:
17465995
16.

Incidence of thyroid carcinoma in fluorodeoxyglucose positron emission tomography-positive thyroid incidentalomas.

King DL, Stack BC Jr, Spring PM, Walker R, Bodenner DL.

Otolaryngol Head Neck Surg. 2007 Sep;137(3):400-4.

PMID:
17765765
17.

The significance and management of incidental [18F]fluorodeoxyglucose-positron-emission tomography uptake in the thyroid gland in patients with cancer.

Eloy JA, Brett EM, Fatterpekar GM, Kostakoglu L, Som PM, Desai SC, Genden EM.

AJNR Am J Neuroradiol. 2009 Aug;30(7):1431-4. doi: 10.3174/ajnr.A1559. Epub 2009 Apr 2.

18.

Evaluation of thyroid FDG uptake incidentally identified on FDG-PET/CT imaging.

Chen W, Parsons M, Torigian DA, Zhuang H, Alavi A.

Nucl Med Commun. 2009 Mar;30(3):240-4. doi: 10.1097/MNM.0b013e328324b431.

PMID:
19262287
19.

Thyroid incidentalomas on FDG PET/CT in patients with non-thyroid cancer - a large retrospective monocentric study.

Kim H, Kim SJ, Kim IJ, Kim K.

Onkologie. 2013;36(5):260-4. doi: 10.1159/000350305. Epub 2013 Apr 15.

PMID:
23689220
20.

Postoperative fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography: an important imaging modality in patients with aggressive histology of differentiated thyroid cancer.

Nascimento C, Borget I, Al Ghuzlan A, Deandreis D, Hartl D, Lumbroso J, Berdelou A, Lepoutre-Lussey C, Mirghani H, Baudin E, Schlumberger M, Leboulleux S.

Thyroid. 2015 Apr;25(4):437-44. doi: 10.1089/thy.2014.0320. Epub 2015 Mar 16.

PMID:
25633259

Supplemental Content

Support Center